|
|
|
|
 |
|
SENSEX
|
 |
148.40
|
0.57%
|
|
26046.95
|
|
|
|
NIFTY
|
 |
449.53
|
0.53%
|
|
85267.66
|
|
|
|
Nasdaq
|
 |
-398.69
|
-1.69%
|
|
23195.17
|
|
|
|
Nikkei 225
|
 |
687.73
|
1.37%
|
|
50836.55
|
|
|
|
FTSE 100
|
 |
-54.17
|
-0.56%
|
|
9649.03
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Emcure Pharmaceuticals Ltd.
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
544210
|
|
ISIN Demat |
INE168P01015
|
|
Book Value (Rs) |
169.51
|
|
|
NSE Code |
EMCURE
|
|
Dividend Yield % |
0.21
|
|
Market Cap (Rs) |
272897.55
|
|
|
TTM PE(x) |
63.44
|
|
TTM EPS(Rs) |
22.69
|
|
Face Value(Rs.) |
10
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
16-04 1981
|
|
Registered Office
|
Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi, Pune, Maharashtra-411057 .
|
|
ISINNO
|
INE168P01015
|
|
Phone
|
020-35070033 / 35070000
|
|
E-mail
|
corporate@emcure.com |
|
URL
|
www.emcure.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Berjis Desai
|
|
Managing Director
|
Satish Mehta
|
|
Company Secretary
|
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|